Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2017 (2017), Article ID 1783545, 3 pages
https://doi.org/10.1155/2017/1783545
Case Report

The Treatment of Clozapine-Withdrawal Delirium with Electroconvulsive Therapy

Adult Mental Health Unit, The Canberra Hospital, ACT Health, GPO Box 825, Canberra, ACT 2601, Australia

Correspondence should be addressed to Anish Modak

Received 7 September 2017; Accepted 16 October 2017; Published 2 November 2017

Academic Editor: Toshiya Inada

Copyright © 2017 Anish Modak and Arne Åhlin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Durst, A. Teitelbaum, G. Katz, and H. Y. Knobler, “Withdrawal from clozapine: the rebound phenomenon,” The Israel Journal of Psychiatry and Related Sciences, vol. 36, no. 2, p. 122, 1999. View at Google Scholar
  2. T. Bastiampillai, V. Juneja, and M. J. Nance, “Clozapine rebound mania,” Australian & New Zealand Journal of Psychiatry, vol. 48, no. 1, pp. 98-99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. K. Stanilla, J. de Leon, and G. M. Simpson, “Clozapine withdrawal resulting in delirium with psychosis: a report of three cases,” Journal of Clinical Psychiatry, vol. 58, no. 6, pp. 252–255, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Bilbily, B. McCollum, and J. de Leon, “Catatonia Secondary to Sudden Clozapine Withdrawal: A Case with Three Repeated Episodes and a Literature Review,” Case Reports in Psychiatry, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  5. E. Stevenson, F. Schembri, D. M. Green, and J. D. Burns, “Serotonin syndrome associated with clozapine withdrawal,” JAMA Neurology, vol. 70, no. 8, pp. 1054-1055, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Margetic and B. Aukst-Margetic, “Neuroleptic malignant syndrome and clozapine withdrawal at the same time?” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 29, no. 1, pp. 145–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ahmed, K. N. R. Chengappa, V. R. Naidu, R. W. Baker, H. Parepally, and N. R. Schooler, “Clozapine withdrawal-emergent dystonias and dyskinesias: a case series,” Journal of Clinical Psychiatry, vol. 59, no. 9, pp. 472–477, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Cerit, B. Tuzun, E. Akpinar, and E. Sahan, “Clozapine withdrawal catatonia refractory to ECT: a case report,” Bulletin of Clinical Psychopharmacology, vol. 22, no. 3, pp. 275–277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. K. Shields, T. Bastiampillai, and T. Mohan, “Managing clozapine discontinuation - Acute and chronic maintenance strategies,” Australian & New Zealand Journal of Psychiatry, vol. 46, no. 11, pp. 1104-1105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Koch, K. Reich, J. Wielopolski et al., “Catatonic Dilemma in a 33-Year-Old Woman: A Discussion,” Case Reports in Psychiatry, vol. 2013, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  11. S. Kumar, S. Sur, and A. Singh, “Catatonia following abrupt stoppage of clozapine,” Australian & New Zealand Journal of Psychiatry, vol. 45, no. 6, article 499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. N. Mendhekar, R. C. Jiloha, and H. S. Duggal, “Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation,” Australian & New Zealand Journal of Psychiatry, vol. 39, no. 10, pp. 947-948, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Bastiampillai, F. Forooziya, and R. Dhillon, “Clozapine-withdrawal catatonia,” Australian & New Zealand Journal of Psychiatry, vol. 43, no. 3, pp. 283-284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, DSM-5, American Psychiatric Association, Arlington, Va, USA, 5th edition, 2013. View at Publisher · View at Google Scholar
  15. A. Francis and A. Lopez-Canino, “Delirium with catatonic features a new subtype?” Psychiatric Times, vol. 36, no. 2, pp. 239–242, 2009. View at Google Scholar
  16. S. Grover, A. Ghosh, and D. Ghormode, “Do patients of delirium have catatonic features? An exploratory study,” Psychiatry and Clinical Neurosciences, vol. 68, no. 8, pp. 644–651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Roy, S. J. Warnick, and R. Balon, “Catatonia Delirium: 3 Cases Treated With Memantine,” Psychosomatics, vol. 57, no. 6, pp. 645–650, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Oldham and H. B. Lee, “Catatonia vis-à-vis delirium: the significance of recognizing catatonia in altered mental status,” General Hospital Psychiatry, vol. 37, no. 6, pp. 554–559, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Santos Nunes and E. Cheniaux, “Delirium and Mania with catatonic features in a Brazilian patient: Response to ECT,” The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 26, no. 1, p. -E3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Roberto, S. Coelho, P. Sales, and I. Costa, “Malignant catatonia and neuroleptic malignant syndrome: two sides of the same coin?” European Psychiatry, vol. 29, p. 1, 2014. View at Publisher · View at Google Scholar
  21. R. M. Nielsen, K. S. Olsen, A. O. Lauritsen, and H. C. Boesen, “Electroconvulsive therapy as a treatment for protracted refractory delirium in the intensive care unit-Five cases and a review,” Journal of Critical Care, vol. 29, no. 5, pp. 881–881.e6, 2014. View at Publisher · View at Google Scholar · View at Scopus